Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Report 2021: Market to Reach $1.3 Billion by 2027 – Polymers Segment to Account for $456.4 Million – ResearchAndMarkets.com

Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Report 2021: Market to Reach $1.3 Billion by 2027 – Polymers Segment to Account for $456.4 Million – ResearchAndMarkets.com




Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Report 2021: Market to Reach $1.3 Billion by 2027 – Polymers Segment to Account for $456.4 Million – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Oral Solid Dosage Forms (OSDF) and Pharma Excipients – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market to Reach $1.3 Billion by 2027

Amid the COVID-19 crisis, the global market for Oral Solid Dosage Forms (OSDF) and Pharma Excipients estimated at US$914.6 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027.

Polymers, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$456.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Alcohols segment is readjusted to a revised 4.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $269.5 Million, While China is Forecast to Grow at 4.6% CAGR

The Oral Solid Dosage Forms (OSDF) and Pharma Excipients market in the U.S. is estimated at US$269.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$225.6 Million by the year 2027 trailing a CAGR of 4.6% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 3.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.

Minerals Segment to Record 4.2% CAGR

In the global Minerals segment, USA, Canada, Japan, China and Europe will drive the 4.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$90.4 Million in the year 2020 will reach a projected size of US$120.8 Million by the close of the analysis period.

China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$146.6 Million by the year 2027.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS (Total 46 Featured):

  • Abitec Corporation
  • Akzo Nobel NV
  • Archer Daniels Midland Company
  • Associated British Foods PLC
  • Avantor Performance Materials LLC
  • BASF SE
  • Cabot Corporation
  • Cargill, Inc.
  • Celanese Corporation
  • Croda International PLC
  • DowDuPont, Inc.
  • Eastman Chemical Company
  • Ferro Corporation
  • FMC Corporation
  • Huntsman Corporation
  • Ingredion, Inc.
  • Innophos Holdings, Inc.
  • J.M. Huber Corporation
  • Kuraray Co., Ltd.
  • Medtronic PLC
  • Merck KGaA
  • Nitta Gelatin, Inc.
  • Procter & Gamble Company, The
  • Royal Dutch Shell PLC
  • The Lubrizol Corporation

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • World Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • World Historic Review for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • World 15-Year Perspective for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Polymers by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Alcohols by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Minerals by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Gelatin by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Sugar & Others by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. REGIONAL MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 46

For more information about this report visit https://www.researchandmarkets.com/r/vf57ut

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900